CDKN2A and atherosclerosis: As cANRIL can influence the PcG-mediated INK4/ARF silencing through recruiting PcG complexes [63–65], Burd and his colleagues speculated that modified cANRIL structure can result in changes in PcG-mediated INK4/ARF silencing and atherosclerosis susceptibility [40].